ATRA
Atara Biotherapeutics Inc
9.40$
-0.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
Atara Biotherapeutics Inc (ATRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -51 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.5 | -6.0 | -17 | -37 | -60 | -88 | -180 | -236 | -181 | -221 | -270 | -193 | -69 | -51 | |
| – | 0.0 | 0.0 | 0.0 | 0.4 | 1.0 | 3.7 | 7.1 | 8.3 | 9.3 | 5.7 | 4.8 | 5.1 | 2.4 | |
| 0.9 | 1.7 | 10 | 10 | 17 | 23 | 34 | 52 | 51 | 54 | 54 | 45 | 27 | 9.8 | |
| – | 0.1 | 11 | 10 | 17 | 23 | 34 | 53 | 51 | 58 | 3.6 | – | – | – | |
| – | 1.1 | 0.0 | 6.2 | -0.7 | 7.2 | 15 | -4.1 | 64 | 53 | -61 | 15 | -31 | -105 | |
| 0.0 | 0.0 | 0.0 | 0.3 | 3.0 | 20 | 36 | 5.7 | 4.5 | 11 | 4.2 | 1.2 | 0.2 | 0.0 | |
| 0.0 | 0.0 | -83 | -220 | 84 | 99 | -196 | 60 | -121 | 22 | 203 | 124 | 8.6 | 18 | |
| – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | 6.7 | 1.5 | 1.2 | 0.6 | – | – | – | |
| – | – | 70 | -4.6 | -0.1 | -0.4 | -7.5 | -6.7 | -1.5 | -1.2 | -0.6 | -0.1 | – | – | |
| – | – | 0.3 | -0.5 | -0.5 | 9.9 | -0.5 | -0.5 | -0.4 | -0.3 | 30 | -0.9 | -0.9 | -0.3 | |
| 15 | 53 | 70 | 259 | 0.5 | 20 | 358 | 189 | 428 | 104 | 53 | 2.0 | 59 | 16 | |
| 13 | 47 | -30 | 1.8 | 24 | 31 | -19 | 14 | 126 | -94 | -14 | -67 | -0.8 | -17 | |
| -2.5 | -6.0 | -17 | -37 | -63 | -108 | -216 | -241 | -185 | -231 | -275 | -194 | -69 | -51 |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.